TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PE Bioprocess Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
30
|
26
|
20 |
| Financial expenses |
10
|
0
|
1 |
| Earnings before taxes |
-7
|
1
|
20 |
| EBITDA |
2
|
0
|
-4 |
| Total assets |
43
|
54
|
62 |
| Current assets |
32
|
32
|
41 |
| Current liabilities |
8
|
5
|
6 |
| Equity capital |
35
|
48
|
56 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.4%
|
88.9%
|
90.3% |
| Turnover per employee |
30
|
26
|
20 |
| Profit as a percentage of turnover |
-23.3%
|
3.8%
|
100% |
| Return on assets (ROA) |
7.0%
|
1.9%
|
33.9% |
| Current ratio |
400%
|
640.0%
|
683.3% |
| Return on equity (ROE) |
-20.0%
|
2.1%
|
35.7% |
| Change turnover |
6
|
5
|
-16 |
| Change turnover % |
23%
|
24%
|
-44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.